News for IRadimed Corporation (IRMD)

Quick Summary: Iradimed (IRMD) stock surged after FDA cleared its MRidium 3870 IV infusion pump system. Analysts forecast an average stock price target o

Operator: Welcome to the IRADIMED Corporation First Quarter of 2025 Financial Results Conference Call. Currently, all participants are in a listen-only mode.

May 05, 2025 / 01:00PM GMTOperator Welcome to the IRADIMED Corporation first-quarter of 2025 financial results conference call. (Operator Instructions) This cal

Discover IRADIMED's record Q1 2025 earnings, growth in IV pump sales, and FDA updates for the 3870 MR IV pump.

IRADIMED CORPORATION (NASDAQ:IRMD) Q1 2025 Earnings Conference Call May 5, 2025 9:00 AM ETCompany ParticipantsRoger Susi - Founder, President & CEOJohn...

For the second quarter of 2025, IRadimed Corporation (IRMD) anticipates its revenue to be between $19.7 million and $19.9 million. The company also forecasts it

\nRevenue: Achieved a record $19.5 million for Q1 2025, surpassing the estimated $19.33 million and marking an 11% increase year-over-year.GAAP EPS: Reported $0.

Iradimed Corporation (IRMD) announced that its first-quarter revenue reached $19.5 million, marking an 11% increase compared to $17.6 million during the same pe

Announces Regular Quarterly Cash Dividend of $0.17 Per Share Reaffirms Full Year 2025 Revenue and Earnings Guidance Reports record revenue of $19.5 million fo

IRADIMED Corporation (IRMD) will release its Q1 2025 financial results on May 5, 2025, before the market opens. A conference call is scheduled for 9:00

**media[607742]**

**media[607513]**

PR NewswireTUCSON, Ariz., March 12, 2025 Thirty-Sixth Consecutive Period of Record Revenue24% Year-Over-Year Revenue Growth and 24% Adjusted EBITDA Margin

**media[561884]**

PR NewswireTUCSON, Ariz., March 4, 2025 TUCSON, Ariz., March 4, 2025 /PRNewswire/ -- AudioEye, Inc. (Nasdaq: AEYE) ("AudioEye" or the "Company"), the indus

IRADIMED CORPORATION (NASDAQ:IRMD) Q4 2024 Earnings Conference Call February 13, 2025 11:00 AM ETCompany ParticipantsRoger Susi - Founder, President and...

iRadimed (IRMD) delivered earnings and revenue surprises of -2.22% and 1.57%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

**media[539927]**

Iradimed (IRMD) reports preliminary Q4 2024 revenue of $19.2M-$19.4M and expects full-year total revenue to be $73.1M-$73.3M, up 11%-12% YoY.